198 related articles for article (PubMed ID: 34865853)
1. Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.
Karmon G; Sragovich S; Hacohen-Kleiman G; Ben-Horin-Hazak I; Kasparek P; Schuster B; Sedlacek R; Pasmanik-Chor M; Theotokis P; Touloumi O; Zoidou S; Huang L; Wu PY; Shi R; Kapitansky O; Lobyntseva A; Giladi E; Shapira G; Shomron N; Bereswill S; Heimesaat MM; Grigoriadis N; McKinney RA; Rubinstein M; Gozes I
Biol Psychiatry; 2022 Jul; 92(1):81-95. PubMed ID: 34865853
[TBL] [Abstract][Full Text] [Related]
2. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
Grigg I; Ivashko-Pachima Y; Hait TA; Korenková V; Touloumi O; Lagoudaki R; Van Dijck A; Marusic Z; Anicic M; Vukovic J; Kooy RF; Grigoriadis N; Gozes I
Transl Psychiatry; 2020 Jul; 10(1):228. PubMed ID: 32661233
[TBL] [Abstract][Full Text] [Related]
3. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
Ivashko-Pachima Y; Gozes I
Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
[TBL] [Abstract][Full Text] [Related]
4. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.
Hacohen-Kleiman G; Sragovich S; Karmon G; Gao AYL; Grigg I; Pasmanik-Chor M; Le A; Korenková V; McKinney RA; Gozes I
J Clin Invest; 2018 Nov; 128(11):4956-4969. PubMed ID: 30106381
[TBL] [Abstract][Full Text] [Related]
5. Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study.
Ivashko-Pachima Y; Hadar A; Grigg I; Korenková V; Kapitansky O; Karmon G; Gershovits M; Sayas CL; Kooy RF; Attems J; Gurwitz D; Gozes I
Mol Psychiatry; 2021 May; 26(5):1619-1633. PubMed ID: 31664177
[TBL] [Abstract][Full Text] [Related]
6. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
[TBL] [Abstract][Full Text] [Related]
7. Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond.
Kapitansky O; Giladi E; Jaljuli I; Bereswill S; Heimesaat MM; Gozes I
J Neural Transm (Vienna); 2020 Feb; 127(2):251-263. PubMed ID: 32072336
[TBL] [Abstract][Full Text] [Related]
8. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
[TBL] [Abstract][Full Text] [Related]
9. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.
Ivashko-Pachima Y; Ganaiem M; Ben-Horin-Hazak I; Lobyntseva A; Bellaiche N; Fischer I; Levy G; Sragovich S; Karmon G; Giladi E; Shazman S; Barak B; Gozes I
Mol Psychiatry; 2022 Aug; 27(8):3316-3327. PubMed ID: 35538192
[TBL] [Abstract][Full Text] [Related]
10. ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case.
D'Incal C; Van Dijck A; Ibrahim J; De Man K; Bastini L; Konings A; Elinck E; Gozes L; Marusic Z; Anicic M; Vukovic J; Van der Aa N; Mateiu L; Vanden Berghe W; Kooy RF
Acta Neuropathol Commun; 2024 Apr; 12(1):62. PubMed ID: 38637827
[TBL] [Abstract][Full Text] [Related]
11. A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.
Gozes I; Shazman S
Eur J Neurosci; 2023 Jul; 58(2):2641-2652. PubMed ID: 36669790
[TBL] [Abstract][Full Text] [Related]
12. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
Gozes I
Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
[TBL] [Abstract][Full Text] [Related]
13. Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting.
Kapitansky O; Karmon G; Sragovich S; Hadar A; Shahoha M; Jaljuli I; Bikovski L; Giladi E; Palovics R; Iram T; Gozes I
Cells; 2020 Oct; 9(10):. PubMed ID: 33086621
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Genotype-Phenotype (Vineland Questionnaire) Characterization of 15 ADNP Syndrome Cases Highlights Mutated Protein Length and Structural Characteristics Correlation with Communicative Abilities Accentuated in Males.
Levine J; Lobyntseva A; Shazman S; Hakim F; Gozes I
J Mol Neurosci; 2024 Jan; 74(1):15. PubMed ID: 38282129
[TBL] [Abstract][Full Text] [Related]
15. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
Shiryaev N; Pikman R; Giladi E; Gozes I
Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
[TBL] [Abstract][Full Text] [Related]
16. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
Ivashko-Pachima Y; Maor-Nof M; Gozes I
PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
[TBL] [Abstract][Full Text] [Related]
17. ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease.
Sragovich S; Merenlender-Wagner A; Gozes I
Bioessays; 2017 Nov; 39(11):. PubMed ID: 28940660
[TBL] [Abstract][Full Text] [Related]
18. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
[TBL] [Abstract][Full Text] [Related]
19. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
Vulih-Shultzman I; Pinhasov A; Mandel S; Grigoriadis N; Touloumi O; Pittel Z; Gozes I
J Pharmacol Exp Ther; 2007 Nov; 323(2):438-49. PubMed ID: 17720885
[TBL] [Abstract][Full Text] [Related]
20. NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms.
Ganaiem M; Gildor ND; Shazman S; Karmon G; Ivashko-Pachima Y; Gozes I
Cells; 2023 Sep; 12(18):. PubMed ID: 37759476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
